Cargando…

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy

BACKGROUND: Some individuals experience a discordant response during antiretroviral therapy (ART), with a blunted CD4+ cell count response despite low HIV-1 RNA plasma levels. MATERIALS AND METHODS: CD4 counts and viral load of 251 individuals on ART referred to the center were analysed for immunolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prabhakar, B., Banu, Asima, Pavithra, H. B., Chandrashekhara, P., Sasthri, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195189/ https://www.ncbi.nlm.nih.gov/pubmed/22021970 http://dx.doi.org/10.4103/2589-0557.85412

Ejemplares similares

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
por: Oliveira, Marta Iglis, et al.
Publicado: (2018)

Early Mortality and AIDS Progression Despite High Initial Antiretroviral Therapy Adherence and Virologic Suppression in Botswana
por: Steele, Katherine T., et al.
Publicado: (2011)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
por: Melku, Mulugeta, et al.
Publicado: (2020)

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
por: Rusconi, S, et al.
Publicado: (2010)

Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in Haiti
por: Charles, Macarthur, et al.
Publicado: (2012)

Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil
por: de Melo, Marineide Gonçalves, et al.
Publicado: (2019)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
por: Bunupuradah, Torsak, et al.
Publicado: (2011)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia
por: Mamo, Ayele, et al.
Publicado: (2022)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
por: Rai, M. Ali, et al.
Publicado: (2022)

Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals
por: Crossley, Kate M., et al.
Publicado: (2016)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia [Corrigendum]
Publicado: (2022)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
por: Bunnell, Kristen L., et al.
Publicado: (2018)

The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy
por: Rosenblum, Michael, et al.
Publicado: (2009)

Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India
por: Dravid, Ameet N., et al.
Publicado: (2018)

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV
por: Mounzer, Karam, et al.
Publicado: (2019)

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
por: Tukei, Vincent J, et al.
Publicado: (2013)

Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China
por: Zheng, Junwen, et al.
Publicado: (2014)

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2017)

Causes of death in vertically infected paediatric HIV-seropositives- Karnataka experience
por: Shastri, Suresh, et al.
Publicado: (2012)

Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
por: Collins, Sean E., et al.
Publicado: (2015)

Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania
por: Gunda, Daniel W., et al.
Publicado: (2017)

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
por: Ananworanich, Jintanat, et al.
Publicado: (2016)

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2017)

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
por: Peluso, Michael J, et al.
Publicado: (2020)

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection
por: van Paassen, Pien M., et al.
Publicado: (2023)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections
por: Mosquera, Diana M, et al.
Publicado: (2019)

Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States
por: Elbur, Abubaker Ibrahim, et al.
Publicado: (2023)

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy
por: Jaworowski, Anthony, et al.
Publicado: (2019)

Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy?
por: French, Clare E., et al.
Publicado: (2014)

Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya
por: Kadima, Julie, et al.
Publicado: (2018)

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment
por: Pyngottu, Ashima, et al.
Publicado: (2020)

KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy
por: Soria, Alessandro, et al.
Publicado: (2011)

Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar
por: Bermúdez-Aza, Elkin Hernán, et al.
Publicado: (2018)

Persistence of Activated and Adaptive-Like NK Cells in HIV(+) Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
por: Hearps, Anna C., et al.
Publicado: (2017)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Virology and Immunology of Bats
por: Schountz, Tony
Publicado: (2013)

Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling, in Children, Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland
por: Jobanputra, Kiran, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bjr0e3v5ij7tmvkog3ek30hold